Corporation China

10/07/2023

Unleash the Power of China -

The Executive Exclusive Society (EES) and China General Chamber of Commerce (CGCC) have jointly launched the China International Entrepreneur Society (CIES), bridging the gap between Eastern and Western business communities. This membership program provides unparalleled access to the vast Chinese ma...

30/05/2023

https://mailchi.mp/corporationchina/exciting-opportunity-for-2023-represent-your-brand-in-china-remotely

JPMorgan raised its 2023 growth outlook to 6.4%, up from a previous forecast of 6%, saying the latest quarterly report points to further growth ahead.

26/09/2018

NEWS ALERT: China releases Official stance on U.S. Trade War *|https://corporationchina.com/news-alert-china-releases-official-stance-on-u-s-trade-war/|*

13/02/2018

Beijing’s municipal government said on Wednesday that it will keep its 2018 economic growth target at around 6.5 percent, on par with the objective that Shanghai has set for itself this year. http://ow.ly/npPf30imFD3

15/01/2018

China Growth – Will 2018 be the year Shenzhen and Guangzhou finally overtake Hong Kong? The southern Chinese city of Shenzhen has marked an economic milestone, surpassing the 2 trillion yuan GDP mark with 8.8 per cent growth in 2017. http://ow.ly/Z3Os30hMfQy

18/10/2017

When the world’s second largest economy sits down to reshuffle its leadership and map out an economic plan for the next five years it is a big deal. It is an especially big deal in Australia given China’s role as our most important trading partner.

28/09/2017

China’s Media Regulator Admonishes Music-Streaming Services. http://ow.ly/Uht230fu0Vh

Sep252017China’s Media Regulator Admonishes Music-Streaming ServicesBreaking News, China Blog, Corporation China News, Go to market, In the NewsBy...

14/09/2017

In a statement on Thursday, Tesla said it needed to set up more overseas factories to make cars that customers could afford. Such a strategy is a must in China, which charges steep tariffs for imported cars.
“Tesla is working with the Shanghai Municipal Government to explore the possibility of establishing a manufacturing facility in the region to serve the Chinese market,” a company spokesman said. “Tesla is deeply committed to the Chinese market, and we continue to evaluate potential manufacturing sites around the globe to serve the local markets.”
Under Chinese law, such a project would require Tesla to find a Chinese joint-venture partner. While China is full of Chevrolets, Fords and Volkswagens, most are made in factories jointly owned by a foreign automaker and a local company.
“However, Tesla could get around the joint-venture requirement by building a wholly owned factory in a foreign trade zone in China.” says Arnodo Neto, Regional Manager for Corporation China in Shanghai.
China accounted for about 15 percent of Tesla’s revenue last year, nearly double the percentage it contributed in 2015. As the City of Shanghai controls the SAIC Motor Corporation, one of China’s largest automakers and a partner for General Motors and Volkswagen, it was not clear whether Tesla’s negotiations with the city government would steer the company to negotiate with SAIC.
“The Chinese market has decreased the gap in comparison to the rest of the world when it comes to electric cars. In fact, at any given area, if you have an entrepreneur spirit, a good idea in mind, or even a existing business you would like to expand to China, there is a lot of room for growth around here.” concludes Neto. http://ow.ly/zW1O30f8JnR

01/09/2017

The world’s largest rice producer is hungry for more and looking to the U.S. for supplies. China will import American rice for the first time after a new trade deal was agreed to Thursday (July, 20).
“The agreement with China has been in the works for more than a decade and I’m pleased to see it finally come to fruition, especially knowing how greatly it will benefit our growers and industry,” said U.S. Agriculture Secretary Sonny Perdue in a statement.
China produces 20 times more rice than the U.S., but it’s also the world’s biggest consumer. Recently it has been buying more rice abroad, spending way over $1 billion in some years, to feed its population.
Last year, China imported about 5 million tons, according to the U.S. Department of Agriculture (USDA). The U.S. alone couldn’t satisfy that demand. America exports between 3 million and 4 million tons a year, according to the UN Food and Agriculture Organization.
China was once largely able to feed itself, especially with rice. But it’s been relying more on imports in recent years. Rising food imports partly reflect challenges in Chinese agriculture. The rural population is aging, crop yields are low and there are high levels of soil depletion. Pollution and climate change also threaten production.
“What we have always to keep in mind is that the commitment among countries represents an opening for improvement and development of guidelines for the future. Evidently, the continuous expansion of our activity assumes important positions in the establishment of new business in China as we support companies since the beginning of their projects,” states Arnodo Guimarães Neto, Regional Manager for Corporation China in Shanghai.
Arnodo continues, “In this way, the increase of the dialogue between the different productive sectors plays an essential role in the formulation of the relationships. Among all the industries willing to come to China, none of them have faced unbeatable barriers.”

The world’s largest rice producer is hungry for more and looking to the U.S. for supplies. China will import American rice for the first time after...

17/08/2017

China is considering taking measures to shorten the time to market for approved imported drugs in an effort to ease a shortage of the medicines, according to the China Food and Drug Administration.
The proposed changes to current clinical trial requirements were in response to public demand for new drugs, the administration said in a document published on its website. The body proposes eliminating a requirement asking applicants who intend to conduct an international multi-centre clinical trial in China for drugs, apart from vaccines, to obtain prior foreign approval or be currently in phase II or III clinical trials overseas.
Imported drugs would be allowed to directly apply for market authorization once completing international multi-centre clinical trials, the document said. High drug costs and a lack of access to the most recent treatments is a major flashpoint in China, where patients often are forced to resort to risky grey markets to get cheaper medicines. http://ow.ly/WLnv30ethAK
“When finalized and implemented, these policies will encourage biopharmaceutical innovation and accelerate the approval process for new medicines,” Pfizer said in a meeting with Corporation China. “They will also pave the way for China’s integration into the system for multi-regional clinical trials that undergirds global drug development.”
But why would these changes mean so much for foreign pharmas? “Before expanding to new markets, companies develop businesses plans, strategies, allocate resources and staff, among many other factors. Having to wait years before receiving a license for sale is a luxury that many companies can not afford, a fast moving Chinese policy on drugs will be crucial to determine pharmas future growth without compromising one of the most valuable assets in today’s business environment: time.” states Arnodo Neto, Regional Manager at Corporation China in Shanghai.